NCT06317584

Brief Summary

This phase study will use a randomized trial method to evaluate the performance of the ECAM educational app in the promotion of CAM health literacy and communication among patients with diabetes.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
88

participants targeted

Target at P25-P50 for not_applicable diabetes

Timeline
Completed

Started May 2024

Shorter than P25 for not_applicable diabetes

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 12, 2024

Completed
7 days until next milestone

First Posted

Study publicly available on registry

March 19, 2024

Completed
2 months until next milestone

Study Start

First participant enrolled

May 17, 2024

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 16, 2024

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 3, 2025

Completed
Last Updated

April 1, 2025

Status Verified

March 1, 2025

Enrollment Period

3 months

First QC Date

March 12, 2024

Last Update Submit

March 26, 2025

Conditions

Keywords

Complementary and Alternative Medicine (CAM)Patient EducationEmpowermentHealth LiteracyApplicationDiabetes

Outcome Measures

Primary Outcomes (3)

  • Understanding the benefits-risks of complementary therapies (CTs) use scale Alternative Medicine (CAM) use questionnaire

    Measure patients' understanding of benefit-risk management on CAM use,The lower the score, the poorer the understanding.

    Pre-test (baseline), 2, 3 months after intervention

  • Quality of life questionnaire

    assess patients' satisfaction with various aspects of life while managing diabetes.

    Pre-test (baseline), 2, 3 months after intervention

  • Diabetes Empowerment scale

    Measure patients' understanding of benefit-risk management on CAM use, the minimum and maximum values,and higher scores .The minimum is 10,maximum values is 40,The lower the score, the poorer the understanding.

    Pre-test (baseline), 2, 3 months after intervention

Study Arms (2)

Empowerment Application for CAM Health Education.

EXPERIMENTAL

Using empowerment software applications for complementary and alternative therapy education, explaining the risk factors that need to be considered, and teaching the use of the assistive tool of the empowerment software application

Other: Experimental: Empowerment Application for CAM Health Education

Written Paper for CAM Health Education.

PLACEBO COMPARATOR

Using written paper for complementary and alternative therapy education, explaining the risk factors that need to be considered

Other: Written Paper for CAM Health Education

Interventions

Using empowerment software application for complementary and alternative therapy education, explaining the risk factors that need to be considered, and teaching the use of assistive tool of the empowerment software application

Empowerment Application for CAM Health Education.

Using written paper for complementary and alternative therapy education and explaining the risk factors that need to be considered

Written Paper for CAM Health Education.

Eligibility Criteria

Age20 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • People over the age of 20
  • diagnosis of diabetes at least 12 months before the interview; and
  • The use of CAM at least 3 months
  • Sufficient mental ability to understand the informed consent form and sign it.

You may not qualify if:

  • Participants will be excluded by an assistant researcher if they serious physical condition and hard of hearing and seeing.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHENG GUNG MEMORIAL HOSPITAL, Linkou

Taoyuan, Guishan District, 333, Taiwan

Location

MeSH Terms

Conditions

Diabetes MellitusEmpowerment

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesSocial BehaviorBehavior

Study Officials

  • Chang Hsiao Yun, PhD

    Chang Gung University of Science and Technology

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
The process of keeping the study group assignment hidden after the allocation to participant, care provider, investigator, outcomes assessor
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Model Details: Randomized trail method
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
professor

Study Record Dates

First Submitted

March 12, 2024

First Posted

March 19, 2024

Study Start

May 17, 2024

Primary Completion

August 16, 2024

Study Completion

January 3, 2025

Last Updated

April 1, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will not share

there is no plan to make individual participant data (IPD) available to other researchers.

Locations